Injecting Highly Viscous Drugs
The author reviews the challenges in delivering macromolecule biologics.

Tackling Drug Shortages
Resolving the problem will require more communication between the industry and regulatory bodies.

Advertisement: Natoli Engineering Company uses the highest quality materials to create efficient, durable and high performing tablet compression tooling. We manufacture all punch configurations including single-tip, multiple-tip, micro tab, exotic shapes, IMA Comprima, die table segments and more, from a variety of high-quality steel types and specialty coatings. Request a quote on our newly redesigned website. Learn more

Advances in Large-Scale Heterocyclic Synthesis
New practical approaches to the synthesis of complex heterocyclic APIs are reviewed.

Advertisement: Agilent Solutions for Quality by Design Agilent’s new QbD Solutions Guide provides information about Agilent tools and technologies to help you minimize variability in analytical method development and analytical method transfer, and support quality by design implementation. Agilent strives to provide solutions you need to be successful, and to earn your trust as a partner in implementing solutions.Download your guide here

GSK Australia Invests in Aseptic Filling
GSK Australia's Boronia site will install next-generation blow-fill-seal machinery for aseptic filling.

Advertisement: Developing a Comprehensive Tool Kit for Microbial Identification November 18, 2014 at 11:00 AM EST To Register Free: www.pharmtech.com/strategy

Shire to Relocate More than 500 Jobs to Massachusetts
Shire will establish its US operational headquarters in Massachusetts and relocate staff from Pennsylvania.

USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
USP and ChP jointly host two-day meeting to strengthen cooperation.

Advertisement: Maximizing Roller Compaction Benefits with Proper Excipient Selection Tuesday, December 09, 2014, 10:00 AM Eastern Standard Time To Register Free: www.pharmtech.com/roller

FDA Requests Comments on Generic Drug Submission Criteria
FDA opens public docket on proposed criteria for “first generic” ANDAs.

FDA Practices Discourage Biologic Market Competition, Says PCMA White Paper
A new report from The Pharmaceutical Care Management Association alleges that FDA hinders competition in the pharmaceutical industry and influences how a drug's price is calculated.

Vetter Opens New Office in Singapore to Support Growing Asian Market
CDMO Vetter has opened a new representative office in Singapore in response to growing market demand in Asia.

EMA Revises Policy on Conflict of Interests
Revised EMA policy reflects more balanced approach and experts are to submit updated declarations of interests by end of January 2015.

Tufts’ New Figures on Drug-Development Costs Spark Debate
Tufts research suggests costs to launch a new drug have doubled since 2003, but some question conclusions.

GSK Leads Big Pharma in Making Its Medicines Accessible
An index from the Access to Medicine Foundation ranks GSK as most effective in making products accessible.